Melatonin may lower prostate cancer risk — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/01/140120085058.htm
Tag Archives: aacr
Possible explanation for link between exercise, improved prostate cancer outcomes — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/01/140120085056.htm
Rapid method to detect BRAF mutations in cancer tissue samples
About 50 percent of melanomas, and less frequently other cancer types, harbor mutations in the BRAF oncogene. …
New nanopharmaceutical may help overcome resistance to anticancer drugs
Antiangiogenic drugs are anticancer drugs designed to cut off the blood supply that brings tumors the nutrients they need to grow and survive, thereby starving and killing the tumor cells. …
Antibody-drug conjugate may provide new treatment option for pancreatic cancer patients
Antibody-drug conjugates are a new type of targeted anticancer therapy, which use an antibody to deliver an attached drug directly to those cells that display the antibody’s target on their surfaces. This precision reduces the side effects of the attached drug compared with conventional systemic administration. Currently, there are two U.S…
New idea for targeting a common cancer protein
Mutant forms of the protein KRAS are found in approximately 30 percent of all cancers. They are responsible for many of the hallmarks of these cancers, and KRAS is, therefore, considered an important therapeutic target. However, attempts to develop clinically useful KRAS-targeted drugs have been unsuccessful. …
Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
About 3 to 5 percent of lung cancers harbor ALK gene abnormalities. The drug crizotinib (Xalkori), which blocks ALK protein kinase activity, was approved in August 2011 by the U.S. Food and Drug Administration for the treatment of patients who have these lung cancers. Although robust responses to crizotinib are observed for lung cancers harboring ALK gene abnormalities, the majority eventually become resistant to the effects of the drug. …